Who Paid My Doc
Fluzone Quadrivalent Northern Hemisphere
Biological Vaccines
NDC 49281-422-10
General payments
$344,049
Research payments
$2,396,427
Through program year 2023, $344,049 in general payments and $2,396,427 in research payments were reported against Fluzone Quadrivalent Northern Hemisphere (Vaccines).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
5 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2023 | General | $228,643 | 9,058 |
| 2023 | Research | $48,076 | 17 |
| 2022 | General | $115,196 | 5,970 |
| 2022 | Research | $2,348,351 | 17 |
| 2021 | General | $209 | 12 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2023.
The top 5 of 103 specialties; each share is of general payments naming this product to practitioners with a specialty in 2023. Each practitioner is counted under their primary specialty.
The top 5 of 50 states; each share is of general payments naming this product in 2023 where a state was reported.
Records
15,040 general · 34 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.